We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Labcorp Buys Personal Genome Diagnostics for $575 Million, Growing Cancer Biopsy Portfolio
Labcorp Buys Personal Genome Diagnostics for $575 Million, Growing Cancer Biopsy Portfolio
Labcorp is buying Personal Genome Diagnostics for up to $575 million, gaining the Baltimore, Md.-based company’s elio range of liquid biopsy and tissue-based products.